share_log

PEAK PHARMACEUTICALS INC | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

SEC ·  Oct 29, 2013 05:14
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.